Open AccessEfficacy analysis of Arbidol treatment in patients with 2019 novel coronavirus pneumonia: a retrospective cohort study
Author(s) -
Nanjin Chen,
Xiaodan Wang,
Sheng Zhang,
Ronghai Lin,
Yongpo Jiang
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-21-2397
Subject(s) - medicine , hazard ratio , confidence interval , retrospective cohort study , covid-19 , cohort , pneumonia , proportional hazards model , disease , infectious disease (medical specialty)
The aim of this study was to determine whether Arbidol has a good antiviral effect on coronavirus disease 2019 (COVID-19).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom